Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas

Adult rhabdomyosarcoma (RMS) represents an uncommon entity with an incidence of less than 3% of all soft tissue sarcomas (STS). Consequently, the natural history and the clinical management of this disease are infrequently reported. In order to fill this gap, we investigated the molecular biology of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alessandro De Vita, Silvia Vanni, Valentina Fausti, Claudia Cocchi, Federica Recine, Giacomo Miserocchi, Chiara Liverani, Chiara Spadazzi, Massimo Bassi, Manlio Gessaroli, Angelo Campobassi, Giovanni De Luca, Federica Pieri, Anna Farnedi, Eugenia Franchini, Anna Ferrari, Chiara Domizio, Enrico Cavagna, Lorena Gurrieri, Alberto Bongiovanni, Nada Riva, Sebastiano Calpona, Giandomenico Di Menna, Silvia Angela Debonis, Toni Ibrahim, Laura Mercatali
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/8578a14c3d6944a6908e1aad77edec19
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8578a14c3d6944a6908e1aad77edec19
record_format dspace
spelling oai:doaj.org-article:8578a14c3d6944a6908e1aad77edec192021-11-11T17:02:52ZDeciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas10.3390/ijms2221115641422-00671661-6596https://doaj.org/article/8578a14c3d6944a6908e1aad77edec192021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11564https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Adult rhabdomyosarcoma (RMS) represents an uncommon entity with an incidence of less than 3% of all soft tissue sarcomas (STS). Consequently, the natural history and the clinical management of this disease are infrequently reported. In order to fill this gap, we investigated the molecular biology of an adult RMS case series. The expression of epithelial mesenchymal transition-related gene and chemoresistance-related gene panels were evaluated. Moreover, taking advantage of our STS translational model combining patient-derived primary culture and 3D-scaffold, the pharmacological profile of an adult head and neck sclerosing RMS was assessed. Furthermore, NGS, microsatellite instability, and in silico analyses were carried out. RT-PCR identified the upregulation of <i>CDH1</i>, <i>SLUG</i>, <i>MMP9</i>, <i>RAB22a</i>, <i>S100P,</i> and <i>LAPTM4b</i>, representing promising biomarkers for this disease. Pharmacological profiling showed the highest sensitivity with anthracycline-based regimen in both 2D and 3D culture systems. NGS analysis detected <i>RAB3IP-HMGA2</i> in frame gene rearrangement and <i>FGFR4</i> mutation; microsatellite instability analysis did not detect any alteration. In silico analysis confirmed the mutation of <i>FGFR4</i> as a promising marker for poor prognosis and a potential therapeutic target. We report for the first time the molecular and pharmacological characterization of rare entities of adult head and neck and posterior trunk RMS. These preliminary data could shed light on this poorly understood disease.Alessandro De VitaSilvia VanniValentina FaustiClaudia CocchiFederica RecineGiacomo MiserocchiChiara LiveraniChiara SpadazziMassimo BassiManlio GessaroliAngelo CampobassiGiovanni De LucaFederica PieriAnna FarnediEugenia FranchiniAnna FerrariChiara DomizioEnrico CavagnaLorena GurrieriAlberto BongiovanniNada RivaSebastiano CalponaGiandomenico Di MennaSilvia Angela DebonisToni IbrahimLaura MercataliMDPI AGarticleadult rhabdomyosarcomaprimary culturegene expression profilingchemotherapy3D collagen-based scaffold culture systemsBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11564, p 11564 (2021)
institution DOAJ
collection DOAJ
language EN
topic adult rhabdomyosarcoma
primary culture
gene expression profiling
chemotherapy
3D collagen-based scaffold culture systems
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle adult rhabdomyosarcoma
primary culture
gene expression profiling
chemotherapy
3D collagen-based scaffold culture systems
Biology (General)
QH301-705.5
Chemistry
QD1-999
Alessandro De Vita
Silvia Vanni
Valentina Fausti
Claudia Cocchi
Federica Recine
Giacomo Miserocchi
Chiara Liverani
Chiara Spadazzi
Massimo Bassi
Manlio Gessaroli
Angelo Campobassi
Giovanni De Luca
Federica Pieri
Anna Farnedi
Eugenia Franchini
Anna Ferrari
Chiara Domizio
Enrico Cavagna
Lorena Gurrieri
Alberto Bongiovanni
Nada Riva
Sebastiano Calpona
Giandomenico Di Menna
Silvia Angela Debonis
Toni Ibrahim
Laura Mercatali
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
description Adult rhabdomyosarcoma (RMS) represents an uncommon entity with an incidence of less than 3% of all soft tissue sarcomas (STS). Consequently, the natural history and the clinical management of this disease are infrequently reported. In order to fill this gap, we investigated the molecular biology of an adult RMS case series. The expression of epithelial mesenchymal transition-related gene and chemoresistance-related gene panels were evaluated. Moreover, taking advantage of our STS translational model combining patient-derived primary culture and 3D-scaffold, the pharmacological profile of an adult head and neck sclerosing RMS was assessed. Furthermore, NGS, microsatellite instability, and in silico analyses were carried out. RT-PCR identified the upregulation of <i>CDH1</i>, <i>SLUG</i>, <i>MMP9</i>, <i>RAB22a</i>, <i>S100P,</i> and <i>LAPTM4b</i>, representing promising biomarkers for this disease. Pharmacological profiling showed the highest sensitivity with anthracycline-based regimen in both 2D and 3D culture systems. NGS analysis detected <i>RAB3IP-HMGA2</i> in frame gene rearrangement and <i>FGFR4</i> mutation; microsatellite instability analysis did not detect any alteration. In silico analysis confirmed the mutation of <i>FGFR4</i> as a promising marker for poor prognosis and a potential therapeutic target. We report for the first time the molecular and pharmacological characterization of rare entities of adult head and neck and posterior trunk RMS. These preliminary data could shed light on this poorly understood disease.
format article
author Alessandro De Vita
Silvia Vanni
Valentina Fausti
Claudia Cocchi
Federica Recine
Giacomo Miserocchi
Chiara Liverani
Chiara Spadazzi
Massimo Bassi
Manlio Gessaroli
Angelo Campobassi
Giovanni De Luca
Federica Pieri
Anna Farnedi
Eugenia Franchini
Anna Ferrari
Chiara Domizio
Enrico Cavagna
Lorena Gurrieri
Alberto Bongiovanni
Nada Riva
Sebastiano Calpona
Giandomenico Di Menna
Silvia Angela Debonis
Toni Ibrahim
Laura Mercatali
author_facet Alessandro De Vita
Silvia Vanni
Valentina Fausti
Claudia Cocchi
Federica Recine
Giacomo Miserocchi
Chiara Liverani
Chiara Spadazzi
Massimo Bassi
Manlio Gessaroli
Angelo Campobassi
Giovanni De Luca
Federica Pieri
Anna Farnedi
Eugenia Franchini
Anna Ferrari
Chiara Domizio
Enrico Cavagna
Lorena Gurrieri
Alberto Bongiovanni
Nada Riva
Sebastiano Calpona
Giandomenico Di Menna
Silvia Angela Debonis
Toni Ibrahim
Laura Mercatali
author_sort Alessandro De Vita
title Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
title_short Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
title_full Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
title_fullStr Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
title_full_unstemmed Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
title_sort deciphering the genomic landscape and pharmacological profile of uncommon entities of adult rhabdomyosarcomas
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/8578a14c3d6944a6908e1aad77edec19
work_keys_str_mv AT alessandrodevita decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT silviavanni decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT valentinafausti decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT claudiacocchi decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT federicarecine decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT giacomomiserocchi decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT chiaraliverani decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT chiaraspadazzi decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT massimobassi decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT manliogessaroli decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT angelocampobassi decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT giovannideluca decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT federicapieri decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT annafarnedi decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT eugeniafranchini decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT annaferrari decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT chiaradomizio decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT enricocavagna decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT lorenagurrieri decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT albertobongiovanni decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT nadariva decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT sebastianocalpona decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT giandomenicodimenna decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT silviaangeladebonis decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT toniibrahim decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
AT lauramercatali decipheringthegenomiclandscapeandpharmacologicalprofileofuncommonentitiesofadultrhabdomyosarcomas
_version_ 1718432188399091712